FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

418747006: Hepatitis B surface antigen immunoglobulin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2006. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3782556017 Hepatitis B surface antigen immunoglobulin (substance) en Fully specified name Active Entire term case sensitive SNOMED CT core module
3782557014 Hepatitis B surface antigen immunoglobulin en Synonym Active Entire term case sensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hepatitis B surface antigen immunoglobulin Is a Immunoglobulin false Inferred relationship Existential restriction modifier
Hepatitis B surface antigen immunoglobulin Is a Human immunoglobulin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hepatitis B immunoglobulin adverse reaction Causative agent True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Hepatitis B immunoglobulin allergy Causative agent False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin 1000iu powder for injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin 200iu powder for injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin 500iu powder for injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Product containing Hepatitis B surface antigen immunoglobulin (medicinal product) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Anti-hbs immunoglobulin injection Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis b immune globulin 1unt/vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis b immune globulin 217u injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis b immune globulin 312units/mL injection solution 1mL vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis b immune globulin 312units/mL injection solution 5mL vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin allergy Causative agent False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Hepatitis B immunoglobulin Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Allergy to Hepatitis b surface antigen immunoglobulin Causative agent True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 312 unit/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 312 unit/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing only Hepatitis B surface antigen immunoglobulin in parenteral dose form (medicinal product form) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing Hepatitis B surface antigen immunoglobulin in parenteral dose form (medicinal product form) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Hepatitis B immunoglobulin 200iu powder for injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Hepatitis B immunoglobulin 500iu powder for injection solution vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier 1
Hepatitis B immunoglobulin human 200unit solution for injection vials (BPL (Bio Products laboratory)) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection vials (BPL (Bio Products laboratory)) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Liberim HB 500unit solution for injection vials (Scottish National Blood Transfusion Service) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 200unit solution for injection vials 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection vials 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 200unit solution for injection vials (BPL (Bio Products laboratory)) 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection vials (BPL (Bio Products laboratory)) 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Liberim HB 500unit solution for injection vials (Scottish National Blood Transfusion Service) 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 5000units/100ml solution for injection vials Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Omri-Hep-B 5000units/100ml solution for injection vials (Omrix Biopharmaceuticals Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 5000units/100ml solution for injection vials 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Omri-Hep-B 5000units/100ml solution for injection vials (Omrix Biopharmaceuticals Ltd) 1 vial Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection pre-filled syringes Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Zutectra 500unit solution for injection pre-filled syringes (Biotest (UK) Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 100units/2ml solution for infusion vials Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500units/10ml solution for infusion vials Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 2000units/40ml solution for infusion vials Has active ingredient False Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatect CP 100units/2ml solution for infusion vials (Biotest (UK) Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatect CP 500units/10ml solution for infusion vials (Biotest (UK) Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatect CP 2000units/40ml solution for infusion vials (Biotest (UK) Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier
Hepatect CP 5000units/100ml solution for infusion vials (Biotest (UK) Ltd) Has active ingredient True Hepatitis B surface antigen immunoglobulin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start